X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Orchid Chemicals Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Orchid Chemicals Quarterly Results   (ORCHID)

Here are the latest quarterly results of Orchid Chemicals. For more details, see the Orchid Chemicals financial fact sheet and Orchid Chemicals share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

Orchid Chemicals Quarterly Results

No. of Mths
Qtr. Ending
3
Jun-16
3
Sep-16
3
Dec-16
3
Mar-17
3
Jun-17
3
Sep-17
3
Dec-17
3
Mar-18
8-Qtr Chart
Click to enlarge
Net Sales Rs m1,9091,8771,8002,0491,3962,0931,4421,558 
Other income Rs m00628654478414 
Turnover Rs m1,9091,8771,8622,1341,4502,1411,5261,572 
Expenses Rs m1,7921,6231,5471,9921,7181,8561,3062,272 
Gross profit Rs m117254253-521-322238136-714 
Depreciation Rs m345347352349336336335326 
Interest Rs m6927126941,2137097557620 
Profit before tax Rs m-920-805-732-1,997-1,313-806-877-1,025 
Tax Rs m-120-120-122-119-169-103-105-101 
Profit after tax Rs m-800-685-610-1,879-1,145-703-772-924 
Gross profit margin %6.113.514.0-25.4-23.111.49.4-45.8 
Effective tax rate %13.014.916.75.912.812.711.99.9 
Net profit margin %-41.9-36.5-33.9-91.7-82.0-33.6-53.5-59.3 
Diluted EPS Rs -9.4 -8.0 -7.2 -22.0 -13.4 -8.3 -9.1 -10.8  
Diluted EPS (TTM) Rs -36.0 -35.9 -32.1 -46.6 -50.6 -50.9 -52.8 -41.6  
 Subscriber Feature                  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Read: Orchid Chemicals 4QFY18 Result Performance Review

More Pharmaceuticals Company Quarterly Results:   ASTRAZENECA PHARMA  ALEMBIC LTD  SUN PHARMA  DISHMAN PHARMA  ALEMBIC PHARMA  

Compare ORCHID PHARMA LTD With:   ASTRAZENECA PHARMA  ALEMBIC LTD  SUN PHARMA  DISHMAN PHARMA  ALEMBIC PHARMA  

Compare ORCHID PHARMA LTD With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Trade Strong; Capital Goods Stocks Lead Gains(12:30 pm)

After opening the day in green, share markets in India have continued the momentum and are presently trading above the dotted line.

Views on news

ORCHID PHARMA LTD Announces Quarterly Results (4QFY18); Net Profit Up 50.8% (Quarterly Result Update)

Aug 24, 2018 | Updated on Aug 24, 2018

For the quarter ended March 2018, ORCHID PHARMA LTD has posted a net profit of Rs 924 m (up 50.8% YoY). Sales on the other hand came in at Rs 2 bn (down 24.0% YoY). Read on for a complete analysis of ORCHID PHARMA LTD's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

Eris Lifesciences Limited (IPO)

Jun 15, 2017

Exposure to high margin specialty products offers promising growth prospects.

More Views on News

Most Popular

Don't Panic in This Falling Market... Do This Instead(The 5 Minute Wrapup)

Oct 5, 2018

Find companies with long term durable moats, which are correcting with the current broader market sell-off.

Why You Should Be Excited, Not Sad, About the 30% Small Cap Crash(Profit Hunter)

Oct 4, 2018

Smallcaps have corrected over 30% since the beginning of the year. Find out why Richa Agarwal views this as an opportunity rather than a threat.

Taxpayers to pay salaries of CEOs/CIOs of Mutual Funds(The Honest Truth)

Oct 5, 2018

Ajit Dayal on the crisis in the market and in the mutual fund industry.

Why Are Investors In Sundaram Small Cap Fund Anxious(Outside View)

Oct 3, 2018

A small cap fund that aims to capitalise on emerging businesses and catch them young. However, its failure in keeping volatility under check is making its investors anxious.

Biggest Corrections in the Stock of Infibeam Avenues(Chart Of The Day)

Oct 3, 2018

Infibeam plunged over 70% last week. This was the second biggest single-day fall. But Infibeam witnessed such sharp falls earlier.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ORCHID PHARMA LTD SHARE PRICE


Oct 16, 2018 03:19 PM

TRACK ORCHID PHARMA LTD

  • Track your investment in ORCHID PHARMA LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ORCHID PHARMA LTD

ORCHID PHARMA LTD 5-YR ANALYSIS

COMPARE ORCHID PHARMA LTD WITH

MARKET STATS